Complex Interventions for a Complex System? Using Systems Thinking to Explore Ways to Address Unhealthy Commodity Industry Influence on Public Health Policy

Document Type : Original Article

Authors

1 Department of Social and Policy Sciences, Faculty of Humanities & Social Sciences, University of Bath, Bath, UK

2 Department of Health, Faculty of Humanities & Social Sciences, University of Bath, Bath, UK

3 Centre of Active Lifestyles, Leeds Beckett University, Leeds, UK

4 School of Management, Marketing, Business & Society, University of Bath, Bath, UK

5 Department of Psychology, Faculty of Humanities & Social Sciences, University of Bath, Bath, UK

Abstract

Background 
Interventions are needed to prevent and mitigate unhealthy commodity industry (UCI) influence on public health policy. Whilst literature on interventions is emerging, current conceptualisations remain incomplete as they lack considerations of the wider systemic complexities surrounding UCI influence, which may limit intervention effectiveness. This study applies systems thinking as a theoretical lens to help identify and explore how possible interventions relate to one another in the systems in which they are embedded. Related challenges to addressing UCI influence on policy, and actions to support interventions, were also explored.
 
Methods 
Online participatory workshops were conducted with stakeholders with expertise in UCIs. A systems map, depicting five pathways to UCI influence, and the Action Scales Model were used to help participants identify interventions and guide discussions. Codebook thematic analysis was used to analyse the data.
 
Results 
Fifty-two stakeholders participated in 23 workshops. Participants identified 27 diverse, interconnected and interdependent interventions corresponding to the systems map’s pathways that reduce the ability of UCIs to influence policy. These include, for example, reform policy financing; regulate public-private partnerships (PPPs); reform science governance and funding; frame and reframe the narrative, challenge neoliberalism and gross domestic product (GDP) growth; leverage human rights; change practices on multistakeholder governance; and reform policy consultation and deliberation processes. Participants also identified four potential key challenges to interventions (ie, difficult to implement or achieve; partially formulated; exploited or misused; requires tailoring for context), and four key actions to help support intervention delivery (ie, coordinate and cooperate with stakeholders; invest in civil society; create a social movement; nurture leadership).
 
Conclusion 
A systems thinking lens revealed the theoretical interdependence between disparate and heterogenous interventions. This suggests that to be effective, interventions need to align, work collectively, and be applied synchronously to different parts of the system, including multiple levels of governance. Importantly, these interventions need to be supported by intermediary actions to be achieved. Urgent action is now required to strengthen healthy alliances and implement interventions

Keywords

References

  1. Gilmore AB, Fabbri A, Baum F, et al. Defining and conceptualising the commercial determinants of health. Lancet. 2023;401(10383):1194-1213. doi:1016/s0140-6736(23)00013-2
  2. Ulucanlar S, Lauber K, Fabbri A, et al. Corporate political activity: taxonomies and model of corporate influence on public policy. Int J Health Policy Manag. 2023;12:7292. doi:34172/ijhpm.2023.7292
  3. World Health Organization (WHO). Global Status Report on Noncommunicable Diseases 2014. Geneva: WHO; 2014.
  4. World Health Organization (WHO). Four Noncommunicable Diseases, Four Shared Risk Factors. https://www.who.int/ncdnet/about/4diseases/en/. Accessed July 21, 2020.
  5. Werbick M, Bari I, Paichadze N, Hyder AA. Firearm violence: a neglected "Global Health" issue. Global Health. 2021;17(1):120. doi:1186/s12992-021-00771-8
  6. Abbott MW. Gambling and gambling-related harm: recent World Health Organization initiatives. Public Health. 2020;184:56-59. doi:1016/j.puhe.2020.04.001
  7. Ulucanlar S, Fooks GJ, Gilmore AB. The policy dystopia model: an interpretive analysis of tobacco industry political activity. PLoS Med. 2016;13(9):e1002125. doi:1371/journal.pmed.1002125
  8. McCambridge J, Mialon M, Hawkins B. Alcohol industry involvement in policymaking: a systematic review. Addiction. 2018;113(9):1571-1584. doi:1111/add.14216
  9. Savell E, Fooks G, Gilmore AB. How does the alcohol industry attempt to influence marketing regulations? A systematic review. Addiction. 2016;111(1):18-32. doi:1111/add.13048
  10. Savell E, Gilmore AB, Fooks G. How does the tobacco industry attempt to influence marketing regulations? A systematic review. PLoS One. 2014;9(2):e87389. doi:1371/journal.pone.0087389
  11. Mialon M, Mialon J. Analysis of corporate political activity strategies of the food industry: evidence from France. Public Health Nutr. 2018;21(18):3407-3421. doi:1017/s1368980018001763
  12. Thomas SL, David J, Randle M, Daube M, Senior K. Gambling advocacy: lessons from tobacco, alcohol and junk food. Aust N Z J Public Health. 2016;40(3):211-217. doi:1111/1753-6405.12410
  13. Hussain Z, van Schalkwyk MCI, Galea S, Petticrew M, Maani N. A qualitative framing analysis of how firearm manufacturers and related bodies communicate to the public on gun-related harms and solutions. Prev Med. 2023;166:107346. doi:1016/j.ypmed.2022.107346
  14. Oreskes N, Conway EM. Merchants of Doubt: How a Handful of Scientists Obscured the Truth on Issues from Tobacco Smoke to Global Warming. New York: Bloomsbury Press; 2010.
  15. Thacker PD. Stealing from the tobacco playbook, fossil fuel companies pour money into elite American universities. BMJ. 2022;378:o2095. doi:1136/bmj.o2095
  16. Wood B, Williams O, Baker P, Nagarajan V, Sacks G. The influence of corporate market power on health: exploring the structure-conduct-performance model from a public health perspective. Global Health. 2021;17(1):41. doi:1186/s12992-021-00688-2
  17. Wood B, Baker P, Sacks G. Conceptualising the Commercial determinants of health using a power lens: a review and synthesis of existing frameworks. Int J Health Policy Manag. 2022;11(8):1251-1261. doi:34172/ijhpm.2021.05
  18. Mialon M, Vandevijvere S, Carriedo-Lutzenkirchen A, et al. Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review. BMJ Open. 2020;10(7):e034082. doi:1136/bmjopen-2019-034082
  19. Mialon M. An overview of the commercial determinants of health. Global Health. 2020;16(1):74. doi:1186/s12992-020-00607-x
  20. de Lacy-Vawdon C, Livingstone C. Defining the commercial determinants of health: a systematic review. BMC Public Health. 2020;20(1):1022. doi:1186/s12889-020-09126-1
  21. Lacy-Nichols J, Marten R, Crosbie E, Moodie R. The public health playbook: ideas for challenging the corporate playbook. Lancet Glob Health. 2022;10(7):e1067-e1072. doi:1016/s2214-109x(22)00185-1
  22. Wiist WH. The Foundations of Corporate Strategies: Comment on "'Part of the solution': food corporation strategies for regulatory capture and legitimacy". Int J Health Policy Manag. 2022;11(11):2732-2735. doi:34172/ijhpm.2022.7174
  23. Wiist WH. Mechanisms underlying corporations as determinants of health. Am J Public Health. 2019;109(2):e1. doi:2105/ajph.2018.304853
  24. McKee M, Stuckler D. Revisiting the corporate and commercial determinants of health. Am J Public Health. 2018;108(9):1167-1170. doi:2105/ajph.2018.304510
  25. Baum FE, Sanders DM, Fisher M, et al. Assessing the health impact of transnational corporations: its importance and a framework. Global Health. 2016;12(1):27. doi:1186/s12992-016-0164-x
  26. Wiist WH. The Bottom Line or Public Health: Tactics Corporations Use to Influence Health and Health Policy, and What We Can Do to Counter Them. Oxford: Oxford University Press; 2010.
  27. Wiist WH. Public health and the anticorporate movement: rationale and recommendations. Am J Public Health. 2006;96(8):1370-1375. doi:2105/ajph.2005.072298
  28. Lencucha R, Thow AM. How neoliberalism is shaping the supply of unhealthy commodities and what this means for NCD prevention. Int J Health Policy Manag. 2019;8(9):514-520. doi:15171/ijhpm.2019.56
  29. Townsend B. Next steps for elevating health on trade and investment policy agendas: Comment on "How neoliberalism is shaping the supply of unhealthy commodities and what this means for NCD prevention". Int J Health Policy Manag. 2020;9(7):312-314. doi:15171/ijhpm.2019.126
  30. Smith J. Towards critical analysis of the political determinants of health: Comment on "How neoliberalism is shaping the supply of unhealthy commodities and what this means for NCD prevention". Int J Health Policy Manag. 2020;9(3):121-123. doi:15171/ijhpm.2019.102
  31. Schram A, Goldman S. Paradigm shift: new ideas for a structural approach to NCD prevention: Comment on "How neoliberalism is shaping the supply of unhealthy commodities and what this means for NCD prevention". Int J Health Policy Manag. 2020;9(3):124-127. doi:15171/ijhpm.2019.105
  32. Lee K, Crosbie E. Understanding structure and agency as commercial determinants of health: Comment on "How neoliberalism is shaping the supply of unhealthy commodities and what this means for NCD prevention". Int J Health Policy Manag. 2020;9(7):315-318. doi:15171/ijhpm.2019.127
  33. Labonté R. Neoliberalism 4.0: the rise of illiberal capitalism: Comment on "How neoliberalism is shaping the supply of unhealthy commodities and what this means for NCD prevention". Int J Health Policy Manag. 2020;9(4):175-178. doi:15171/ijhpm.2019.111
  34. Herrick C. On the perils of universal and product-led thinking: Comment on "How neoliberalism is shaping the supply of unhealthy commodities and what this means for NCD prevention". Int J Health Policy Manag. 2020;9(5):209-211. doi:15171/ijhpm.2019.109
  35. Friel S, Collin J, Daube M, et al. Commercial determinants of health: future directions. Lancet. 2023;401(10383):1229-1240. doi:1016/s0140-6736(23)00011-9
  36. Chung-Hall J, Craig L, Gravely S, Sansone N, Fong GT. Impact of the WHO FCTC over the first decade: a global evidence review prepared for the Impact Assessment Expert Group. Tob Control. 2019;28(Suppl 2):s119-s128. doi:1136/tobaccocontrol-2018-054389
  37. Bertscher A, Nobles J, Zatonski M, et al. Building a qualitative systems map: applying systems thinking to the commercial determinants of health and industry influence on health policy. Eur J Public Health. 2022;32(Suppl 3):ckac129.088. doi:1093/eurpub/ckac129.088
  38. Peeters S, Costa H, Stuckler D, McKee M, Gilmore AB. The revision of the 2014 European tobacco products directive: an analysis of the tobacco industry's attempts to 'break the health silo'. Tob Control. 2016;25(1):108-117. doi:1136/tobaccocontrol-2014-051919
  39. Tobacco Tactics. Third Party Techniques. 2019. https://tobaccotactics.org/wiki/Third-Party-Techniques/. Accessed June 11, 2020.
  40. Hird TR, Gallagher AWA, Evans-Reeves K, et al. Understanding the long-term policy influence strategies of the tobacco industry: two contemporary case studies. Tob Control. 2022;31(2):297-307. doi:1136/tobaccocontrol-2021-057030
  41. Knai C, Petticrew M, Capewell S, et al. The case for developing a cohesive systems approach to research across unhealthy commodity industries. BMJ Glob Health. 2021;6(2):e003543. doi:1136/bmjgh-2020-003543
  42. Knai C, Petticrew M, Mays N, et al. Systems thinking as a framework for analyzing commercial determinants of health. Milbank Q. 2018;96(3):472-498. doi:1111/1468-0009.12339
  43. Milsom P, Smith R, Walls H. A systems thinking approach to inform coherent policy action for NCD prevention: Comment on "How neoliberalism is shaping the supply of unhealthy commodities and what this means for NCD prevention". Int J Health Policy Manag. 2020;9(5):212-214. doi:15171/ijhpm.2019.113
  44. Meadows DH. Thinking in Systems: A Primer. London, UK: Chelsea Green Publishing; 2008.
  45. Chavez-Ugalde Y, Toumpakari Z, White M, De Vocht F, Jago R. Using group model building to frame the commercial determinants of dietary behaviour in adolescence - proposed methods for online system mapping workshops. BMC Med Res Methodol. 2022;22(1):84. doi:1186/s12874-022-01576-y
  46. Barbrook-Johnson P, Penn AS. Systems Mapping: How to Build and Use Causal Models of Systems. Cham: Palgrave Macmillan; 2022.
  47. Barbrook-Johnson P, Penn A. Participatory systems mapping for complex energy policy evaluation. Evaluation. 2021;27(1):57-79. doi:1177/1356389020976153
  48. Jebb SA, Finegood DT, Diez Roux A, et al. Systems-Based Approaches in Public Health: Where Next? London: Academy of Medical Sciences, Canadian Academy of Health Sciences; 2020.
  49. Glenn J, Kamara K, Umar ZA, Chahine T, Daulaire N, Bossert T. Applied systems thinking: a viable approach to identify leverage points for accelerating progress towards ending neglected tropical diseases. Health Res Policy Syst. 2020;18(1):56. doi:1186/s12961-020-00570-4
  50. Cavill N, Richardson D, Faghy M, Bussell C, Rutter H. Using system mapping to help plan and implement city-wide action to promote physical activity. J Public Health Res. 2020;9(3):1759. doi:4081/jphr.2020.1759
  51. Kamath V, Biju S, Kamath GB. A Participatory Systems Mapping (PSM) based approach towards analysis of business sustainability of rural Indian milk dairies. Cogent Econ Finance. 2019;7(1):1622172. doi:1080/23322039.2019.1622172
  52. Kim DH. Systems Thinking Tools: A User's Reference Guide. Waltham: Pegasus Communications; 1994.
  53. Nobles JD, Radley D, Mytton OT. The Action Scales Model: a conceptual tool to identify key points for action within complex adaptive systems. Perspect Public Health. 2022;142(6):328-337. doi:1177/17579139211006747
  54. Sterman JD. Learning from evidence in a complex world. Am J Public Health. 2006;96(3):505-514. doi:2105/ajph.2005.066043
  55. Checkland P. Systems thinking and soft systems methodology. In: The Oxford Handbook of Management Information Systems. Oxford University Press; 2011.
  56. Peters DH. The application of systems thinking in health: why use systems thinking? Health Res Policy Syst. 2014;12:51. doi:1186/1478-4505-12-51
  57. Meadows DH. Leverage Points: Places to Intervene in a System. Sustainability Institute; 1999.
  58. Andersen DF, Calhoun A, Hovmand PS, et al. Scriptapedia. 2021. https://en.wikibooks.org/wiki/Scriptapedia. Accessed April 27, 2022.
  59. Braun V, Clarke V. Thematic Analysis: A Practical Guide. SAGE Publications; 2021.
  60. Leung JYY, Casswell S. The WHO Foundation should not accept donations from the alcohol industry. BMJ Glob Health. 2022;7(5):e008707. doi:1136/bmjgh-2022-008707
  61. Hirono K, Haigh F, Gleeson D, Harris P, Thow AM, Friel S. Is health impact assessment useful in the context of trade negotiations? A case study of the Trans Pacific Partnership Agreement. BMJ Open. 2016;6(4):e010339. doi:1136/bmjopen-2015-010339
  62. Cohen JE, Zeller M, Eissenberg T, et al. Criteria for evaluating tobacco control research funding programs and their application to models that include financial support from the tobacco industry. Tob Control. 2009;18(3):228-234. doi:1136/tc.2008.027623
  63. Aveyard P, Yach D, Gilmore AB, Capewell S. Should we welcome food industry funding of public health research? BMJ. 2016;353:i2161. doi:1136/bmj.i2161
  64. Sula-Raxhimi E, Butzbach C, Brousselle A. Planetary health: countering commercial and corporate power. Lancet Planet Health. 2019;3(1):e12-e13. doi:1016/s2542-5196(18)30241-9
  65. Buse K, Tanaka S, Hawkes S. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure. Global Health. 2017;13(1):34. doi:1186/s12992-017-0255-3
  66. Freedhoff Y, Hébert PC. Partnerships between health organizations and the food industry risk derailing public health nutrition. CMAJ. 2011;183(3):291-292. doi:1503/cmaj.110085
  67. Hickel J. What does degrowth mean? A few points of clarification. Globalizations. 2021;18(7):1105-1111. doi:1080/14747731.2020.1812222
  68. Hickel J. Less is More: How Degrowth Will Save the World. Random House; 2020.
  69. Hickel J, Kallis G, Jackson T, et al. Degrowth can work - here's how science can help. Nature. 2022;612(7940):400-403. doi:1038/d41586-022-04412-x
  70. Downie C. Business actors, political resistance, and strategies for policymakers. Energy Policy. 2017;108:583-592. doi:1016/j.enpol.2017.06.018
  71. Battams S. Neo-liberalism, policy incoherence and discourse coalitions influencing non-communicable disease strategy: Comment on "How neoliberalism is shaping the supply of unhealthy commodities and what this means for NCD prevention". Int J Health Policy Manag. 2020;9(3):116-118. doi:15171/ijhpm.2019.95
  72. Glasgow S, Schrecker T. The double burden of neoliberalism? Noncommunicable disease policies and the global political economy of risk. Health Place. 2015;34:279-286. doi:1016/j.healthplace.2015.06.005
  73. Baker P, Hawkes C, Wingrove K, et al. What drives political commitment for nutrition? A review and framework synthesis to inform the United Nations Decade of Action on Nutrition. BMJ Glob Health. 2018;3(1):e000485. doi:1136/bmjgh-2017-000485
  74. Matthes BK, Robertson L, Gilmore AB. Needs of LMIC-based tobacco control advocates to counter tobacco industry policy interference: insights from semi-structured interviews. BMJ Open. 2020;10(11):e044710. doi:1136/bmjopen-2020-044710
  75. Walls HL. Wicked problems and a 'wicked' solution. Global Health. 2018;14(1):34. doi:1186/s12992-018-0353-x
  76. Setzer J, Vanhala LC. Climate change litigation: A review of research on courts and litigants in climate governance. Wiley Interdiscip Rev Clim Change. 2019;10(3):e580. doi:1002/wcc.580
  77. Vanhala L, Kinghan J. Literature Review on the Use and Impact of Litigation. The Public Law Project; 2018.
  78. Bader M, Saage-Maaß M, Terwindt C. Strategic litigation against the misconduct of multinational enterprises. Verfassung und Recht in Übersee/Law and Politics in Africa, Asia and Latin America. 2019;52(2):156-171.
  79. Ehs T. Democratisation Through Participation in Juristocracy: Strategic Litigation Before the ECJ. In: Pausch M, ed. Perspectives for Europe: Historical Concepts and Future Challenges. Baden-Baden: Nomos; 2020:119-126.
  80. Open Society Foundations (OSF). Potential Benefits of Strategic Litigation. OSF; 2016.
  81. Buckel S, Pichl M, Vestena CA. Legal struggles: a social theory perspective on strategic litigation and legal mobilisation. Soc Leg Stud. 2023. doi:1177/09646639231153783
  82. Shawa R, Coomans F, Cox H, London L. A promising potential: using the right to enjoy the benefits of scientific progress to advance public health in Africa. Afr Hum Rights Law J. 2023;23(1):30-47. doi:17159/1996-2096/2023/v23n1a2
  83. Green D. How Change Happens. Oxford University Press; 2016.
  84. Crutchfield LR. How Change Happens: Why Some Social Movements Succeed While Others Don't. John Wiley & Sons; 2018.
  85. Douglas R. A framework for healthy alliances. In: Scriven A, ed. Alliances in Health Promotion: Theory and Practice. London: Palgrave; 1998:3-17. doi:1007/978-1-349-14297-2_1
  86. Backet-Milburn K, MacHardy L. Healthy alliances depend on healthy social processes. In: Scriven A, ed. Alliances in Health Promotion: Theory and Practice. London: Palgrave; 1998:35-43. doi:1007/978-1-349-14297-2_3
  87. Abson DJ, Fischer J, Leventon J, et al. Leverage points for sustainability transformation. Ambio. 2017;46(1):30-39. doi:1007/s13280-016-0800-y
  88. Fischer J, Riechers M. A leverage points perspective on sustainability. People Nat (Hoboken). 2019;1(1):115-120. doi:1002/pan3.13
  89. Senge PM. The Fifth Discipline: The Art and Practice of the Learning Organization. Doubleday; 2006.
  90. D’Alisa G, Kallis G. Degrowth and the state. Ecol Econ. 2020;169:106486. doi:1016/j.ecolecon.2019.106486
  91. Friel S, Arthur M, Frank N. Power and the planetary health equity crisis. Lancet. 2022;400(10358):1085-1087. doi:1016/s0140-6736(22)01544-6
  92. Kallis G, Kerschner C, Martinez-Alier J. The economics of degrowth. Ecol Econ. 2012;84:172-180. doi:1016/j.ecolecon.2012.08.017
  93. Sekulova F, Kallis G, Rodríguez-Labajos B, Schneider F. Degrowth: from theory to practice. J Clean Prod. 2013;38:1-6. doi:1016/j.jclepro.2012.06.022
  94. Paulson L, Büchs M. Public acceptance of post-growth: Factors and implications for post-growth strategy. Futures. 2022;143:103020. doi:1016/j.futures.2022.103020
  95. McAlister MM, Zhang Q, Annis J, Schweitzer RW, Guidotti S, Mihelcic JR. Systems thinking for effective interventions in global environmental health. Environ Sci Technol. 2022;56(2):732-738. doi:1021/acs.est.1c04110
  96. Carey G, Malbon E, Carey N, Joyce A, Crammond B, Carey A. Systems science and systems thinking for public health: a systematic review of the field. BMJ Open. 2015;5(12):e009002. doi:1136/bmjopen-2015-009002
  97. Felmingham T, Backholer K, Hoban E, Brown AD, Nagorcka-Smith P, Allender S. Success of community-based system dynamics in prevention interventions: a systematic review of the literature. Front Public Health. 2023;11:1103834. doi:3389/fpubh.2023.1103834
  98. Allender S, Orellana L, Crooks N, et al. Four-year behavioral, health-related quality of life, and BMI outcomes from a cluster randomized whole of systems trial of prevention strategies for childhood obesity. Obesity (Silver Spring). 2021;29(6):1022-1035. doi:1002/oby.23130
  99. Baugh Littlejohns L, Near E, McKee G, Rasali D, Naiman D, Faulkner G. A scoping review of complex systems methods used in population physical activity research: do they align with attributes of a whole system approach? Health Res Policy Syst. 2023;21(1):18. doi:1186/s12961-023-00961-3
  100. Schwarte L, Samuels SE, Capitman J, Ruwe M, Boyle M, Flores G. The Central California Regional Obesity Prevention Program: changing nutrition and physical activity environments in California's heartland. Am J Public Health. 2010;100(11):2124-2128. doi:2105/ajph.2010.203588
  101. Sanigorski AM, Bell AC, Kremer PJ, Cuttler R, Swinburn BA. Reducing unhealthy weight gain in children through community capacity-building: results of a quasi-experimental intervention program, Be Active Eat Well. Int J Obes (Lond). 2008;32(7):1060-1067. doi:1038/ijo.2008.79
  102. Economos CD, Hyatt RR, Goldberg JP, et al. A community intervention reduces BMI z-score in children: Shape Up Somerville first year results. Obesity (Silver Spring). 2007;15(5):1325-1336. doi:1038/oby.2007.155
  103. de Silva-Sanigorski AM, Bell AC, Kremer P, et al. Reducing obesity in early childhood: results from Romp & Chomp, an Australian community-wide intervention program. Am J Clin Nutr. 2010;91(4):831-840. doi:3945/ajcn.2009.28826
  104. Calancie L, Fullerton K, Appel JM, et al. Implementing group model building with the Shape Up Under 5 community committee working to prevent early childhood obesity in Somerville, Massachusetts. J Public Health Manag Pract. 2022;28(1):E43-e55. doi:1097/phh.0000000000001213
  105. NHS England. Putting Health into Place. NHS England; 2019.
  106. Bachani D, Saxena S, Akbar MA, Gupta R, Basnet S, Pomeroy-Stevens A. Healthier cities through systems thinking: practical considerations for city leaders. J Urban Health. 2022;99(4):733-737. doi:1007/s11524-022-00655-1
  107. o B, Wolf LE, Berkeley A. Conflict-of-interest policies for investigators in clinical trials. N Engl J Med. 2000;343(22):1616-1620. doi:1056/nejm200011303432206
  108. Ralston R, Hil SE, da Silva Gomes F, Collin J. Towards preventing and managing conflict of interest in nutrition policy? An analysis of submissions to a consultation on a draft WHO tool. Int J Health Policy Manag. 2021;10(5):255-265. doi:34172/ijhpm.2020.52
  109. Wiersma M, Kerridge I, Lipworth W. Dangers of neglecting non-financial conflicts of interest in health and medicine. J Med Ethics. 2018;44(5):319-322. doi:1136/medethics-2017-104530
  110. Lacy-Nichols J, Cullerton K. A proposal for systematic monitoring of the commercial determinants of health: a pilot study assessing the feasibility of monitoring lobbying and political donations in Australia. Global Health. 2023;19(1):2. doi:1186/s12992-022-00900-x
  111. Logical Framework Analysis. London: BOND; 2003.
  112. Public Health England. Introduction to Logic Models. 2018. https://www.gov.uk/government/publications/evaluation-in-health-and-well-being-overview/introduction-to-logic-models. Accessed February 3, 2023.
  113. Guidance on Using the Revised Logical Framework. London: DIFD; 2011.
  114. Anderson A. The Community Builder's Approach to Theory of Change: A Practical Guide to Theory Development. Washington, DC: The Aspen Institute; 2006.
  115. United Nations Development Group (UNDG). Theory of Change UNDAF Companion Guidance. UNDG; 2017.
  116. Chari R, Hogan J, Murphy G, Crepaz M. Regulating lobbying: a global comparison. In: Regulating Lobbying. 2nd ed. Manchester University Press; 2020.

Files

History

  • Receive Date: 19 March 2023
  • Revise Date: 08 September 2023
  • Accept Date: 25 February 2024
  • First Publish Date: 27 February 2024

Share

How to cite

Statistics